Myokardia, inc. (MYOK)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Cash flow from operating activities:
Net loss

-308,611

-276,213

-233,122

-107,109

-87,348

-67,698

-62,088

-63,020

-60,068

-57,010

-29,913

-22,423

-16,722

-10,380

-35,320

-31,551

-26,866

-22,946

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense

36,765

32,994

29,596

26,547

22,691

19,341

15,430

11,805

8,364

6,138

5,379

4,541

3,804

2,813

2,051

1,430

895

516

0

0

0

Depreciation

2,200

1,900

1,900

1,800

1,800

1,600

1,423

1,366

1,284

1,300

1,273

1,214

1,171

1,111

1,039

1,003

967

965

0

0

0

Amortization of discount on investments

1,745

1,619

1,186

882

573

279

104

9

-65

-85

0

0

0

-

-

-

-

-

-

-

-

Loss on disposal of equipment

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

0

0

0

Change in fair value of redeemable convertible preferred stock call option liability, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

314

0

0

0

Change in operating assets and liabilities:
Receivable from collaboration partner

-

-

-

-

-

-1,013

2,565

0

0

-43,987

0

0

0

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

2,834

2,612

4,651

1,334

1,992

2,884

1,021

1,362

507

482

783

176

568

112

140

500

502

852

0

0

0

Operating lease right-of-use assets

-3,049

-2,618

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

-

-290

378

113

163

296

-3

37

100

59

0

0

0

-

-

-

-

-

-

-

-

Accounts payable

647

3,064

3,903

254

2,409

671

496

1,553

-50

367

166

-486

310

-434

516

366

863

1,301

0

0

0

Accrued liabilities

10,333

11,665

16,547

11,985

10,022

8,945

8,039

2,886

3,324

2,968

4,252

4,670

2,303

3,250

2,878

2,524

2,203

2,940

0

0

0

Prepayment from collaboration partner

-

12,973

10,943

6,859

4,602

-8,541

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

-

1,907

1,862

-1,480

-827

-178

-135

-122

-119

-120

-152

-152

-142

-109

-124

44

136

454

0

0

0

Deferred revenue

-

-

-

-

-

-33,558

-24,112

-18,001

-14,363

-11,442

30,190

29,718

29,169

28,029

-14,199

-14,200

-14,199

-14,199

0

0

0

Net cash used in operating activities

-263,620

-241,769

-206,699

-97,730

-86,247

-64,815

-53,659

-55,805

-54,471

-9,838

10,301

16,843

19,218

-20,856

-43,287

-40,834

-36,453

-32,100

0

0

0

Purchases of investments

-

259,897

229,846

134,473

133,423

132,475

48,421

47,617

43,773

44,044

0

0

0

-

-

-

-

-

-

-

-

Sales of investments

4,000

4,000

0

0

0

-

-

-

-

4,000

0

0

0

-

-

-

-

-

-

-

-

Maturities of investments

158,475

78,000

59,000

45,000

36,000

28,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

15,078

3,264

2,334

2,710

2,998

3,373

3,617

3,256

2,520

1,517

1,146

934

706

1,083

926

931

1,446

1,446

0

0

0

Proceeds from sale of equipment

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

134

0

0

0

Net cash provided by (used in) investing activities

-79,803

-181,161

-169,180

-80,183

-88,460

-99,848

-24,028

-34,863

-34,244

-37,551

-57,250

-49,016

-44,786

-17,143

-926

-931

-1,386

-1,252

0

0

0

Proceeds from issuance of common stock in follow-on offerings, net of issuance and financing costs

-

271,224

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Payments of financing related costs

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

0

0

-

-

-

-

Proceeds from exercise of stock options and employee stock purchase plan

8,608

7,071

4,613

5,695

5,682

6,208

5,865

4,285

3,150

2,365

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

8,347

278,295

275,837

276,713

459,030

188,071

187,665

320,216

137,012

136,189

196,983

61,833

61,637

61,501

56,788

56,304

101,717

101,969

0

0

0

Net increase in cash, cash equivalents and restricted cash

-335,076

-144,635

-100,042

98,800

284,323

23,408

109,978

229,548

48,297

88,800

150,034

29,660

36,069

23,502

12,575

14,539

63,878

68,617

0

0

0

Non-cash investing and financing activities:
Unpaid portion of property and equipment purchases included in period-end accounts payable and accrued liabilities

11,201

9,756

1,999

99

721

468

403

451

521

283

134

309

164

103

20

46

31

61

0

0

0

Vesting of early exercised options and restricted stock

-

15

24

36

43

53

72

117

148

184

202

191

255

272

283

283

219

177

0

0

0

Unpaid financing-related costs

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unpaid portion of property and equipment purchases included in period-end accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

98

0

0

0

Accretion of dividends on redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,151

0

0

0